Breaking Down Precision Medicine

UNC Lineberger designs, develops and delivers CAR-T therapy to to attack cancers.

UNC Lineberger designs, develops and delivers CAR-T therapy to to attack cancers.

The Lineberger Comprehensive Care Center at Carolina is revolutionizing cancer treatments in the Southeastern region of the United States.

UNC Lineberger is one of only a select few academic centers in the country with the scientific, technical and clinical abilities to treat cancers that fail to respond to standard treatments. The center is working todesign, develop and deliver chimeric antigen T-cell, or CAR-T therapies, to infuse into new tumor targets. Since these therapies are not commercially available, UNC Lineberger is making it possible for people who live in or near the Southeastern U.S. to stay closer to home to undergo clinical immunotherapy treatment for cancer.

Read the complete Carolina Story from UNC Lineberger…Opens in new window

UNC Lineberger Comprehensive Cancer Center Funding Priorities

Readers Also Viewed...

Shelley Earp unc Lineberger

Advancing Cancer Research and Care Across Carolina and the Globe

As a nationally recognized cancer researcher and current director of UNC Lineberger Comprehensive Care Center, Shelton “Shelley” Earp is as comfortable in the lab as he is cheering for the Tar Heels in the Dean Dome.


From Cancer Patient to Volunteer

“In this position I feel like I’ve been given a purpose, and I wouldn’t have had this opportunity before. To be a part of cancer therapies, even my own, is a very special thing.”


Winning His Battle, Helping Others Fight Theirs

The Champ and ET Mitchell Fund for Blood Cancer Research will accelerate research at UNC Lineberger Comprehensive Cancer Center.


Helping to unlock the mysteries of cancer

"There’s no reason those discoveries can't be made right here in Chapel Hill."


An Investment In People

"This is an opportunity for us to continue our work investing in excellent education for the benefit of the entire state."


Drug delivery device toxic for tumors, not patients

"It's an exciting approach; we hit the tumor hard with little toxicity, leaving room for other therapy."